Effects of cannabis use on outcomes of psychotic disorders: systematic review
- PMID: 18978312
- DOI: 10.1192/bjp.bp.107.046375
Effects of cannabis use on outcomes of psychotic disorders: systematic review
Abstract
Background: It is unclear if research findings support clinical opinion that cannabis use leads to worse outcomes in people with psychosis, or whether this impression is confounded by other factors.
Aims: To systematically review the evidence pertaining to whether cannabis affects outcome of psychotic disorders.
Method: We searched 10 relevant databases (to November 2006), reference lists of included studies and contacted experts. We included 13 longitudinal studies from 15,303 references. Data extraction and quality assessment were conducted independently and in duplicate.
Results: Cannabis use was consistently associated with increased relapse and non-adherence. Associations with other outcome measures were more disparate. Few studies adjusted for baseline illness severity, and most made no adjustment for alcohol, or other potentially important confounders. Adjusting for even a few confounders often resulted in substantial attenuation of results.
Conclusions: Confidence that most associations reported were specifically due to cannabis is low. Despite clinical opinion, it remains important to establish whether cannabis is harmful, what outcomes are particularly susceptible, and how such effects are mediated. Studies to examine this further are eminently feasible.
Similar articles
-
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.Lancet. 2007 Jul 28;370(9584):319-28. doi: 10.1016/S0140-6736(07)61162-3. Lancet. 2007. PMID: 17662880 Review.
-
Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.Br J Psychiatry. 2006 Aug;189:137-43. doi: 10.1192/bjp.bp.105.014308. Br J Psychiatry. 2006. PMID: 16880483
-
Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.Psychol Med. 2015 Jul;45(9):1977-88. doi: 10.1017/S0033291714003092. Epub 2015 Feb 5. Psychol Med. 2015. PMID: 25654244
-
[Motivational interviewing for cannabis users with psychotic disorders].Encephale. 2007 Oct;33(5):819-26. doi: 10.1016/j.encep.2006.08.001. Encephale. 2007. PMID: 18357854 French.
-
Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry. J Clin Psychiatry. 2010. PMID: 20331929 Review.
Cited by
-
Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta-analysis.Brain Behav. 2024 Jan;14(1):e3340. doi: 10.1002/brb3.3340. Brain Behav. 2024. PMID: 38376038 Free PMC article. Review.
-
Biobehavioral Interactions between Endocannabinoid and Hypothalamicpituitary- adrenal Systems in Psychosis: A Systematic Review.Curr Neuropharmacol. 2024;22(3):495-520. doi: 10.2174/1570159X21666230801150032. Curr Neuropharmacol. 2024. PMID: 37533248
-
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.Schizophr Bull. 2023 Jul 4;49(4):903-913. doi: 10.1093/schbul/sbad033. Schizophr Bull. 2023. PMID: 36999551
-
Delta-8-THC association with psychosis: A case report with literature review.Front Psychiatry. 2023 Feb 20;14:1103123. doi: 10.3389/fpsyt.2023.1103123. eCollection 2023. Front Psychiatry. 2023. PMID: 36890985 Free PMC article.
-
Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences.Front Psychiatry. 2023 Jan 10;13:1037451. doi: 10.3389/fpsyt.2022.1037451. eCollection 2022. Front Psychiatry. 2023. PMID: 36704748 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
